Leading City of Hope hematologists appointed to new positions
New drug shows strong results against stubborn mutation
June 5, 2019 | Michael Easterling
A new drug being investigated by Marwan Fakih, M.D., professor in the Department of Medical Oncology & Therapeutics Research and medical director of the Judy & Bernard Briskin Center for Clinical Research, is "potentially practice-changing," Fakih said.
Archives
Steven Rosen inducted into the Association of American Physicians
June 19, 2019 | Michael Easterling
Provost and Chief Scientific Officer Steven T. Rosen, M.D., the Irell & Manella Cancer Center Director’s Distinguished Chair, has been inducted as a member of the Association of American Physicians (AAP). Membership to the AAP is bestowed upon those physicians who indicate a "pre-eminence and the highest caliber of physician-led science accomplishments and scientific leadership."
Scientist honored for 'digging into the DNA of cancer'
June 17, 2019 | City of Hope
Dr. Jianjun Chen was recently named the Simms/Mann Family Foundation Chair in Systems Biology. Chen was recognized with the endowment for his leading-edge cancer research that is founded in personalized, gene-based medicine.
City of Hope investigator awarded $1 million ORIEN NOVA Grant
June 11, 2019 | Maxine Nunes
The dynamic young founder and director of City of Hope’s Precision Imaging Lab, Ammar Chaudhry, M.D., is one of the first recipients of the new ORIEN NOVA Award. The $1 million grant will fund research for his breakthrough approach to cancer imaging and diagnosis.
CIRM Awards City of Hope Researchers $3.7 million to Develop Glioblastoma Clinical Trial
September 28, 2018 | Letisia Marquez
California Institute for Regenerative Medicine has awarded City of Hope $3.7 million to develop a phase 1 clinical trial for glioblastoma patients, which would genetically alter blood stem cells to better tolerate chemotherapy.
CIRM Grants Nearly $6M to Promising Sickle Cell Research
May 15, 2018 | Michael Easterling
City of Hope’s Joseph Rosenthal, M.D., and his team can advance their research into finding a cure for sickle cell disease, thanks to a $5.74 million award from the California Institute for Regenerative Medicine.
City of Hope Researcher Seeks New Cure for Hemophilia
February 21, 2018 | Katie Neith
Saswati Chatterjee, Ph.D., a professor in the Department of Surgery and member of the Beckman Research Institute at City of Hope, thinks she may know a way to cure hemophilia A.
City of Hope's CEACAM Research Comes Full Circle with New CAR T Approach
February 9, 2018 | Jyoti Madhusoodanan
More than 50 years after its discovery, CEA remains one of the most widely used clinical markers of cancer. As the diverse roles of CEA and its family members, known as CEA-related cell adhesion molecules (CEACAMs), have grown clearer, researchers at City of Hope are working on a new wave of clinical tools and therapies.
New Postdoc Receives Grant to Support Work on Kaposi Sarcoma
January 23, 2018 | Katie Neith
A recent recruit to Beckman Research Institute of City of Hope has received a three-year grant from the St. Baldrick's Foundation to support his work on a vaccine for Kaposi sarcoma.
